Significant loss of bone mass in patients with early, active ankylosing spondylitis: A followup study

Arthritis and Rheumatism

Volumn 42, Issue 11, 1999, Pages 2319-2324

  Gratacos J ^a,d   Collado, A ^b   Pons, F ^b   Osaba, M ^b   Sanmarti R ^b   Roque M ^c   Larrosa, M ^a   Munoz Gomez J ^b  

^a Parc Taulí Health Corporation   (Spain)

^b HOSPITAL CLÍNIC   (Spain)

^c Programs and Hlth Serv CEPSS/FPT   (Spain)

^d Parc Tauli Health Corporation   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ANKYLOSING SPONDYLITIS; ARTICLE; BONE ATROPHY; BONE DENSITY; BONE MASS; CLINICAL ARTICLE; DISEASE ACTIVITY; DISEASE ASSOCIATION; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; FEMUR NECK; HUMAN; INFLAMMATION; LUMBAR SPINE; MALE; PRIORITY JOURNAL;

ADULT; BONE RESORPTION; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; LONGITUDINAL STUDIES; LUMBAR VERTEBRAE; MALE; SPONDYLITIS, ANKYLOSING;

EID: 0033504715     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/1529-0131(199911)42:11<2319::AID-ANR9>3.0.CO;2-G     Document Type: Article

References (27)

1. Dequeker J, Gueusens P. Osteoporosis and arthritis. Ann Rheum Dis 1990;49:276-80.
2. Spencer DG, Park WM, Dick HM, Papazoglou SN, Buchanan WW. Radiologic manifestations in 200 patients with AS: correlation with clinical studies and HLA-B27. J Rheumatol 1979;6:305-15.
3. Will R, Bhalla AK, Palmer R, Ring R, Calin A. Osteoporosis in early ankylosing spondylitis: a primary pathological event? Lancet 1989;II:1483-5.
4. Ralston SH, Urquhart GD, Brzeski M, Sturrock RD. Prevalence of vertebral compression fractures due to osteoporosis in ankylosing spondylitis. BMJ 1990;300:563-5.
5. Cooper C, Carbone L, Michet CJ, Atkinson EJ, O'Fallon WM, Melton JL. Fracture risk in patients with ankylosing spondylitis: a population based study. J Rheumatol 1994;21:1877-82.
6. Devogelaer J-P, Maldague B, Malghem J, Nagant de Deuxchaisnes C. Appendicular and vertebral bone mass in ankylosing spondylitis: a comparison of plain radiographs with single-and dual-photon absorptiometry and with quantitative computed tomography. Arthritis Rheum 1992;35:1062-7.
7. Jimenez-Balderas FJ, Tapia-Serrano R, Madero-Cervera JI, Murrieta S, Mintz G. Ovarian function studies in active ankylosing spondylitis in women: clinical response to estrogen therapy. J Rheumatol 1990;17:497-502.
8. Keck E, Franck H. Serum osteocalcin and vitamin D metabolites in patients with ankylosing spondylitis. Ann Rheum Dis 1993;52: 543-6.
9. Lee YS, Schlotzhauer T, Ott SM, van Vollenhoven RF, Hunter J, Shapiro J, et al. Skeletal status of men with early and late ankylosing spondylitis. Am J Med 1997;103:233-41.
10. Genant HK, Wu CY, van Kuijk C, Nevitt MC. Vertebral fracture assessment using a semiquantitative technique. J Bone Miner Res 1993;8:1137-48.
11. Daltroy LH, Larson MG, Roberts WN, Liang MH. A modification of the Health Assessment Questionnaire for the spondyloarthropathies. J Rheumatol 1990;17:946-50.
12. Matthews JNS, Altman DG, Campbell MJ, Royston P. Analysis of serial measurements in medical research. BMJ 1990;300:230-5.
13. Gratacós J, Collado A, Filella X, Sanmartí R, Cañete J, Llena J, et al. Serum cytokines (IL-6, TNFα, IL-1β and IFN-γ) in ankylosing spondylitis: a close correlation between serum IL-6 and disease activity and severity. Br J Rheumatol 1994;33:927-31.
14. Laan R, van Riel P, van de Putte L. Bone mass in patients with rheumatoid arthritis. Ann Rheum Dis 1992;51:826-32.
15. MacDonald BR, Gowen M. Scientific reviews in rheumatology: cytokines and bone. Br J Rheumatol 1992;31:149-55.
16. Gough A, Sambrook P, Devlin J, Huisson A, Njeh C, Robbins S, et al. Osteoclastic activation is the principal mechanism leading to secondary osteoporosis in rheumatoid arthritis. J Rheumatol 1998;25:1282-9.
17. Dolan AL, Moniz C, Dasgupta B, Li F, Mackintosh C, Todd P, et al. Effects of inflammation and treatment on bone turnover and bone mass in polymyalgia rheumatica. Arthritis Rheum 1997;40: 2022-9.
18. Fujimori A, Tsutsumi M, Fukore M, Yamaha H, Fujita T. Cyclooxygenase enhances cell growth in an osteoblastic cell line, MC3T3-E1. J Bone Miner Res 1989;4:697-704.
19. Toussirot E, Ricard-Blum S, Dumoulin G, Cedoz JP, Wendung D. Relationship between urinary pyridinium cross-links, disease activity and disease subsets of ankylosing spondylitis. Rheumatology 1999;38:21-7.
20. Laurent MR, Panayi GS. Acute-phase proteins and serum immunoglobulins in ankylosing spondylitis. Ann Rheum Dis 1983;42: 524-8.
21. Nashel DJ, Petrone DL, Ulmer CC, Sliwinski AJ. C-reactive protein: a marker for disease activity in ankylosing spondylitis and Reiter's syndrome. J Rheumatol 1986;13:364-7.
22. Manolagas SC, Jilka RL. Bone marrow, cytokines and bone remodeling: emerging insights into the pathophysiology of osteoporosis. N Engl J Med 1995;332:305-11.
23. Russell RGG, Rahman S, Al-Himodan AK. The immune system and bone in osteoporosis. In: Christiansen C, Overgaard K, editors. Osteoporosis. Copenhagen: Osteopress; 1990. p. 1523-5.
24. Will R, Palmer A, Bhalla AK, Ring F, Calin A. Bone loss as well as bone formation is a feature of progressive ankylosing spondylitis. Br J Rheumatol 1990;29:498-9.
25. Donnelly S, Doyle DV, Denton A, Rolfe I, McCloskey EV, Spector TD. Bone mineral density and vertebral compression fracture rates in ankylosing spondylitis. Ann Rheum Dis 1994;53: 117-21.
26. Guthrie J, Ebeling PR, Hopper JL, Barret-Connor E, Dennerstein L, Dudley EC, et al. A prospective study of bone loss in menopausal Australian-born women. Osteoporos Int 1998;8: 282-90.
27. Bronson WD, Walker SE, Hillman LS, Keisler D, Hoyt T, Allen S. Bone mineral density and biochemical markers of bone metabolism in ankylosing spondylitis. J Rheumatol 1998;25:929-35.